Trade Summary

1 week ago, Horn Howard, serving as Chief Financial Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 4,698 shares at $33.13 per share, for a total transaction value of $155,644.74. Following this transaction, Horn Howard now holds 100,991 shares of RARE.

This sale represents a 4.45% decrease in Horn Howard's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, July 1, 2026 and publicly disclosed via SEC Form 4 filing on Monday, July 6, 2026 at 3:37 PM ET, 5 days after the trade was made.

Ultragenyx Pharmaceutical Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.